- Home
- RVYL vs LSBPW Comparison
RVYL vs LSBPW Comparison
Compare RVYL & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVYL
- LSBPW
- Stock Information
- Founded
- RVYL 2007
- LSBPW N/A
- Country
- RVYL United States
- LSBPW China
- Employees
- RVYL N/A
- LSBPW 758
- Industry
- RVYL Professional Services
- LSBPW Biotechnology: Pharmaceutical Preparations
- Sector
- RVYL Consumer Discretionary
- LSBPW Health Care
- Exchange
- RVYL Nasdaq
- LSBPW Nasdaq
- Market Cap
- RVYL 13.3M
- LSBPW N/A
- IPO Year
- RVYL N/A
- LSBPW N/A
- Fundamental
- Price
- RVYL $2.06
- LSBPW $0.07
- Analyst Decision
- RVYL Hold
- LSBPW
- Analyst Count
- RVYL 1
- LSBPW 0
- Target Price
- RVYL N/A
- LSBPW N/A
- AVG Volume (30 Days)
- RVYL 94.9K
- LSBPW N/A
- Earning Date
- RVYL 11-11-2024
- LSBPW N/A
- Dividend Yield
- RVYL N/A
- LSBPW N/A
- EPS Growth
- RVYL N/A
- LSBPW N/A
- EPS
- RVYL N/A
- LSBPW N/A
- Revenue
- RVYL $68,403,000.00
- LSBPW N/A
- Revenue This Year
- RVYL N/A
- LSBPW N/A
- Revenue Next Year
- RVYL $46.18
- LSBPW N/A
- P/E Ratio
- RVYL N/A
- LSBPW N/A
- Revenue Growth
- RVYL 42.88
- LSBPW N/A
- 52 Week Low
- RVYL $0.89
- LSBPW N/A
- 52 Week High
- RVYL $5.48
- LSBPW N/A
- Technical
- Relative Strength Index (RSI)
- RVYL 62.76
- LSBPW N/A
- Support Level
- RVYL $1.91
- LSBPW N/A
- Resistance Level
- RVYL $2.30
- LSBPW N/A
- Average True Range (ATR)
- RVYL 0.26
- LSBPW 0.00
- MACD
- RVYL 0.06
- LSBPW 0.00
- Stochastic Oscillator
- RVYL 71.84
- LSBPW 0.00
About RVYL Ryvyl Inc.
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.
About LSBPW LakeShore Biopharma Co. Ltd
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.